Folding and Design of Beta Sheets in Membranes
膜中β片的折叠和设计
基本信息
- 批准号:7715396
- 负责人:
- 金额:$ 1.64万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2001
- 资助国家:美国
- 起止时间:2001-04-01 至 2010-12-31
- 项目状态:已结题
- 来源:
- 关键词:AlgorithmsAntibioticsBiologicalBiological ModelsBiomedical EngineeringBiosensorBiotechnologyChlamydiaChloroplastsDatabasesDrug Delivery SystemsDrug DesignEngineeringFamilyFigs - dietaryGenomeGenomicsGenus MycobacteriumGoalsGram-Negative BacteriaHemolysinHost DefenseHumanIntegral Membrane ProteinLibrariesLifeLipid BilayersLipidsMembraneMembrane ProteinsMethodsMitochondriaPeptide AntibioticsPeptidesProteinsProteomeProteomicsResearchScreening procedureStaphylococcus aureusStructureStructure-Activity RelationshipSystemThermodynamicsToxinVenomsVesicleVirulenceanthrax toxinantimicrobialantimicrobial peptidebasebeta pleated sheetcombinatorial chemistrycytotoxicdesigndriving forceengineering designhigh throughput screeninginterestmemberpathogenpeptide structureprogramsself assembly
项目摘要
DESCRIPTION (provided by applicant): Integral membrane proteins comprise about 25% of all genomes. Those that use the b-barrel motif comprise up to 4% of the genomes of Gram-negative bacteria, and are also present in mycobacteria, chlamydiae, mitochondria and chloroplasts. Exogenous proteins and peptides that self-assemble into b-sheets in membranes are also found in all kingdoms of life, including humans, where they are involved in pathogen virulence and host defense and in the action of many toxins and venoms. For example, the Anthrax toxin and the a-hemolysin of Staphylococcus aureus use b-barrels to permeabilize membranes. There are also many pore-forming peptide antibiotics that are predominantly b-sheet structure. In this ongoing research program we are pursuing a deeper understanding of the driving forces and structure-function relationships for the self-assembly of b-sheets in synthetic and biological membranes in order to design self-assembling b-sheet peptides that have interesting and useful structures and functions in membranes, and in order to identify b-barrel membrane proteins, predict their structure and engineer their function. The methods we are using for designing and engineering pore-forming peptides and for characterizing antimicrobial and cytotoxic activity have potentially important biotechnology applications in the fields of antibiotics, biosensors and drug delivery. These broad goals will be accomplished through the following lines of experimentation. Design new families of pore-forming peptides by screening libraries for members that self-assemble into pores in lipid bilayer membranes. Characterize the mechanism of pore formation in lipid vesicles and the structure of the peptide and cross characterize the antimicrobial activity of pore formers. Design and characterize pore-forming peptides by screening libraries for potent, broad-spectrum antimicrobial activity. Cross characterize antimicrobial peptides in vesicle-based systems to compare the determinants of structure and function in the two systems. Use combinatorial chemistry and high throughput screening to design peptides that self-assemble into membrane-spanning, protein-like b-barrel pores. Finally we will use genomics and proteomics to delineate the b-barrel proteomes of Gram-negative bacteria and validate b-barrel prediction algorithms. This information will be used to create a public database of potential outer membrane proteins
描述(由申请人提供):整合膜蛋白约占所有基因组的 25%。使用 b 桶基序的基因占革兰氏阴性细菌基因组的高达 4%,并且也存在于分枝杆菌、衣原体、线粒体和叶绿体中。在包括人类在内的所有生命王国中也发现了在膜中自组装成 b-折叠的外源蛋白质和肽,它们参与病原体毒力和宿主防御以及许多毒素和毒液的作用。例如,炭疽毒素和金黄色葡萄球菌的a-溶血素使用b-桶来透化膜。还有许多成孔肽抗生素主要是b-片层结构。在这个正在进行的研究项目中,我们正在寻求更深入地了解合成膜和生物膜中 B-片层自组装的驱动力和结构功能关系,以便设计具有有趣且有用的自组装 B-片层肽膜中的结构和功能,并为了识别 b 桶膜蛋白、预测其结构并设计其功能。我们用于设计和改造成孔肽以及表征抗菌和细胞毒活性的方法在抗生素、生物传感器和药物输送领域具有潜在的重要生物技术应用。这些广泛的目标将通过以下实验来实现。通过筛选库中自组装到脂质双层膜孔中的成员,设计新的成孔肽家族。表征脂质囊泡中孔形成的机制和肽的结构,并交叉表征孔形成剂的抗菌活性。通过筛选具有有效、广谱抗菌活性的文库来设计和表征成孔肽。交叉表征基于囊泡的系统中的抗菌肽,以比较两个系统中结构和功能的决定因素。使用组合化学和高通量筛选来设计可自组装成跨膜、类似蛋白质 b 桶孔的肽。最后,我们将使用基因组学和蛋白质组学来描绘革兰氏阴性细菌的 b 桶蛋白质组并验证 b 桶预测算法。该信息将用于创建潜在外膜蛋白的公共数据库
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
WILLIAM C WIMLEY其他文献
WILLIAM C WIMLEY的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('WILLIAM C WIMLEY', 18)}}的其他基金
Structure and Function of Direct Delivery Peptides
直接递送肽的结构和功能
- 批准号:
10717736 - 财政年份:2023
- 资助金额:
$ 1.64万 - 项目类别:
Mechanism of Resistance Avoidance in Synthetically Evolved Antibacterial Peptides
合成进化抗菌肽避免耐药性的机制
- 批准号:
10412134 - 财政年份:2021
- 资助金额:
$ 1.64万 - 项目类别:
Mechanism of Resistance Avoidance in Synthetically Evolved Antibacterial Peptides
合成进化抗菌肽避免耐药性的机制
- 批准号:
10308818 - 财政年份:2021
- 资助金额:
$ 1.64万 - 项目类别:
相似国自然基金
放线菌吲哚-噁唑类抗生素的生物合成机制及其组合生物合成研究
- 批准号:32360009
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
人工甜味剂诱导蚯蚓肠道抗生素抗性基因的增长行为及微生物驱动机制
- 批准号:42307015
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
光能辅助浮动型微生物电化学修复系统构建与强化抗生素去除机制
- 批准号:52300199
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
利用多功能AMP-连接酶的底物宽泛性改造脂肽类抗生素SF2768的生物合成途径
- 批准号:32370087
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
基于生物类芬顿的LA/Sch@BB耦合系统去除水产养殖尾水中抗生素的效果与机制研究
- 批准号:42377063
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
相似海外基金
Leveraging Molecular Technologies to Improve Diagnosis and Management of Pediatric Acute Respiratory Illness in Resource-Constrained Settings
利用分子技术改善资源有限环境中儿科急性呼吸系统疾病的诊断和管理
- 批准号:
10739603 - 财政年份:2023
- 资助金额:
$ 1.64万 - 项目类别:
Scalable and Interoperable framework for a clinically diverse and generalizable sepsis Biorepository using Electronic alerts for Recruitment driven by Artificial Intelligence (short title: SIBER-AI)
使用人工智能驱动的招募电子警报的临床多样化和通用脓毒症生物库的可扩展和可互操作框架(简称:SIBER-AI)
- 批准号:
10576015 - 财政年份:2023
- 资助金额:
$ 1.64万 - 项目类别:
Discovery and characterization of synthetic bioinformatic natural product anticancer agents
合成生物信息天然产物抗癌剂的发现和表征
- 批准号:
10639302 - 财政年份:2023
- 资助金额:
$ 1.64万 - 项目类别:
Noninvasive Diagnostic Markers of Lower Respiratory Tract Infection in Mechanically Ventilated Patients
机械通气患者下呼吸道感染的无创诊断标志物
- 批准号:
10697471 - 财政年份:2023
- 资助金额:
$ 1.64万 - 项目类别:
Clinical decision support algorithm to optimize management of respiratory tract infection in children attending primary health facilities in Kilimanjaro Region, Tanzania
用于优化坦桑尼亚乞力马扎罗地区初级卫生机构儿童呼吸道感染管理的临床决策支持算法
- 批准号:
10734148 - 财政年份:2023
- 资助金额:
$ 1.64万 - 项目类别: